Lucy Glazebrook

Lucy Glazebrook, CPA, currently serves as Advisory Director at Embark, a position held since October 2025. Prior to this role, Lucy was Associate Director of Financial Reporting and Technical Accounting at TScan Therapeutics from September 2022 to October 2025 and held various positions within TScan Therapeutics from July 2021 to April 2022, including Sr. Manager of SEC Reporting and Accounting and Financial Reporting Manager. Lucy's early career included the role of Associate Director of Financial Reporting at Seres Therapeutics for a brief period in 2022 and several positions at KPMG US, where Lucy progressed from Audit Intern in 2013 to Audit Manager by 2021. Educational qualifications include a Bachelor of Business Administration and a Master's degree in Accounting, both from the University of Massachusetts at Amherst - Isenberg School of Management.